Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>IMS</strong> COM PANY PRO FILES NOVARTIS<br />
<strong>IMS</strong> Sales Data<br />
Pharmaceutical Sales by Geographical Region and Leading Countries<br />
Country Share<br />
of Regional<br />
Corporate Sales<br />
%<br />
Percentage<br />
Growth Sep<br />
07/Sep 08<br />
USD USD FIXED<br />
RATE<br />
TOTAL SALES 100.0 8 1<br />
EUROPE 41.6 22 8<br />
GERMANY 28.1 22 8<br />
FRANCE 14.8 21 7<br />
ITALY 8.6 22 8<br />
SPAIN 7.8 23 9<br />
UNITED KINGDOM 5.8 8 8<br />
NORTH AMERICA 37.1 -10 -11<br />
U.S.A. 92.6 -12 -12<br />
CANADA 7.4 22 11<br />
ASIA, AFRICA & AUSTRALASIA 16.2 20 11<br />
JAPAN 44.5 19 7<br />
TURKEY 14.0 23 10<br />
AUSTRALIA 8.5 40 25<br />
KOREA 5.5 9 15<br />
CHINA HOSPITAL 3.8 29 19<br />
LATIN AMERICA 5.0 25 15<br />
BRAZIL RETAIL 44.5 44 21<br />
MEXICO RETAIL 21.2 2 -1<br />
VENEZUELA RETAIL 11.2 52 52<br />
ARGENTINA RETAIL 6.1 14 14<br />
PUERTO RICO 5.9 3 3<br />
The com pany’s phar ma ceu ti cal sales are an a lyzed in terms of geo graph ical re gion, and within each re -<br />
gion the ma jor coun tries pre sented. Sales data cov ers the twelve months to Sep tem ber 2008. See Ap -<br />
pen dix for coun try universe sourced.<br />
Sales and growth for the au dited Latin Amer i can coun tries are pre sented in US dol lars only. The de ci sion<br />
for con ver sion to US dol lars was due to ex ces sive in fla tion and sub se quent de val u a tions lead ing to both<br />
lo cal cur rency and ex change rates ex ceed ing the field sizes avail able for them on the MIDAS database.<br />
Novartis Total Sales by Top Five Markets<br />
Source: <strong>IMS</strong> Health<br />
Others<br />
37%<br />
Japan<br />
7%<br />
Italy<br />
4%<br />
France<br />
6%<br />
Sales by Top 5 Markets<br />
USA<br />
34%<br />
Germany<br />
12%<br />
© 2009 <strong>IMS</strong> Health In cor po rated or its af fil i ates Page 118
Change language